pharma · Steroid refractory Acute Graft versus host Disease · moderate to severe atopic dermatitis
Medac Gesellschaft fuer
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Medac Gesellschaft fuer is a pharma organization headquartered in EU. Primary therapeutic focus areas include Steroid refractory Acute Graft versus host Disease, moderate to severe atopic dermatitis. NovaPharmaNews links
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 3
- Drugs
- 14
- Patents
- 0
MC-MSC.1/aGvHD
Phase 3 · small molecule · Steroid refractory Acute Graft versus host Disease
MC-MSC.1/aGvHD for Steroid refractory Acute Graft versus host Disease is a Phase 3 program (small_molecule) at Medac Gesellschaft fuer klinische Spezialpraeparate mbH with 1 ClinicalTrials.gov record(s).
Internal code MC-MSC.1/aGvHD
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Steroid refractory Acute Graft versus host Disease
- Status
- active
- Trials
- 1